Real-World Study of Young Patients With Solid Tumors in China

Sponsor
Fudan University
Study ID
NCT07708935
Status
Recruiting
Apply to this trial

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Ages 18-40 — OTHER
    Young Cohort (Core Population): Patients aged ≤40 years at the time of initial diagnosis of a malignant tumor. Older Control Cohort: Patients aged \>40 years at the time of initial diagnosis of a malignant tumor, selected proportionally according to the incidence of each tumor type and propensity score matching principles.

Study Details

To evaluate organ preservation rates, fertility preservation, and long-term quality of life after treatment among young patients.

Key Dates

First listed
Jul 16, 2026
Start date
Jul 31, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
12,000 participants (estimated)

Arms

  • Arm: Young Patients with Malignant Solid Tumors
    Young Patients with Malignant Solid Tumors

Primary Outcome Measure

Assessment of Special Needs and Quality of Life (QoL) [ Time Frame: January 1, 2010 to December 31, 2027 ]

Central Contacts

Related Studies